Ferronova Cancer Screening Bio Tech Australia

Transforming the precision of cancer imaging, surgery and therapy

Our vision is to give everyone diagnosed with cancer their best chance to become cancer free

Transforming the precision of cancer imaging, surgery and therapy

Our vision is to give everyone diagnosed with cancer their best chance to become cancer free

We believe that by bringing together world-class expertise in chemistry, bioengineering and medicine we can identify solutions that will transform the accuracy of early cancer staging. Ensuring that no cancer goes undetected has the potential to allow surgeons and pathologists to maximise the use of their skills, support less-invasive procedures, and improve outcomes for patients.

 

What gives us purpose

We all know someone – a friend or a family member – who is facing a cancer diagnosis. And, collectively, we have witnessed too many people close to us find hope that they are cancer free, only to be told later that ‘the cancer is back’.

We believe that by bringing together world-class expertise in chemistry, bioengineering and medicine we can identify solutions that will transform the accuracy of early cancer staging. Ensuring that no cancer goes undetected has the potential to allow surgeons and pathologists to maximise the use of their skills, support less-invasive procedures, and improve outcomes for patients.

 

Ultimately, for our families, and yours, we are driven to continue pushing the boundaries of nanotechnology to help make sure no one dies unnecessarily because cancer was missed.

Our history

Core IP University of Sydney

1990

Research into medical applications

2000

Collaboration in head and neck cancer

2010

Collaboration between the University of South Australia, University of Adelaide, and Royal Adelaide Hospital

Ferronova incorporated investment

2016

Seed investment for Ferronova

Preclinical validation studies

2016 - 2020

"

Ethics for colorectal trial with Ingham

May 2021

Ingham Institute

Start Oral Cancer first in human trial

2020

Royal Adelaide Hospital and Uni of Adelaide

BMTH grant for colorectal
trial

2020

Ingham Institute, UniSA, UniSyd

Series A Funding

2020

Led by Uniseed

FerroTrace-FAPI research program

2019

Collaboration between NHMRC Grants, University of South Australia, UNSW, and Uni Q

"

Start Breast Cancer Study

June 2021

Collaboration between The Royal Melbourne Hospital and Peter MacCallum Cancer Centre.

Our core values

what we stand for

We solve big problems

Difficult projects don’t scare us

We value relationships

Respectful and considerate – always

We’re an open book

Transparency in all that we do

We care

Our desire to help comes form the heart

Who

backs us

Ferronova seed funding has been supported by a range of investors-including Uniseed and Artesian Venture Partners.

The South Australian Government have also provided grant funding to enable the further progression of clinical trials.